mTOR mediates a mechanism of resistance to chemotherapy and defines a rational combination strategy to treat KRAS-mutant lung cancer
暂无分享,去创建一个
R. Schmid | E. Vassella | C. Riether | A. Ochsenbein | S. Hall | S. Berezowska | Hai-xia Yang | Duo Xu | S. Liang | T. Marti | G. Kocher | R. Peng | M. A. Amrein | E. D. Bührer | L. Froment | Zhang Yang | Elias D. Bührer | M. Amrein